Identification of potential novel N6-methyladenosine effector-related lncRNA biomarkers for serous ovarian carcinoma: a machine learning-based exploration in the framework of 3P medicine

BackgroundSerous ovarian carcinoma (SOC) is considered the most lethal gynecological malignancy. The current lack of reliable prognostic biomarkers for SOC reduces the efficacy of predictive, preventive, and personalized medicine (PPPM/3PM) in patients with SOC, leading to unsatisfactory therapeutic...

Full description

Bibliographic Details

Published in:	Frontiers in Pharmacology
Main Authors:	Lele Ye, Xinya Tong, Kan Pan, Xinyu Shi, Binbing Xu, Xuyang Yao, Linpei Zhuo, Su Fang, Sangsang Tang, Zhuofeng Jiang, Xiangyang Xue, Weiguo Lu, Gangqiang Guo
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-06-01
Subjects:	m6A modification immunotherapy biomarker RP11-508M8.1 predictive preventive
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1351929/full